NGL Fine-Chem
Ticker > Company >

NGL Fine-Chem share price

NGL Fine-Chem Ltd.

NSE: NGLFINE BSE: 524774 SECTOR: Pharmaceuticals & Drugs  47k   256   41

1298.00
+46.90 (3.75%)
NSE: Today, 10:14 AM

Price Summary

Today's High

₹ 1299

Today's Low

₹ 1251.1

52 Week High

₹ 2777.95

52 Week Low

₹ 957

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 801.91 Cr.

Enterprise Value

₹ 834.31 Cr.

No. of Shares

0.62 Cr.

P/E

27.18

P/B

2.86

Face Value

₹ 5

Div. Yield

0.14 %

Book Value (TTM)

₹  453.36

CASH

₹ 1.6 Cr.

DEBT

₹ 34 Cr.

Promoter Holding

72.74 %

EPS (TTM)

₹  47.75

Sales Growth

19.6%

ROE

15.78 %

ROCE

18.93%

Profit Growth

91.46 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year19.6%
3 Year8.41%
5 Year16.52%

Profit Growth

1 Year91.48%
3 Year-11.49%
5 Year13.77%

ROE%

1 Year15.78%
3 Year17.98%
5 Year21.63%

ROCE %

1 Year18.93%
3 Year21.71%
5 Year26.14%

Debt/Equity

0.1294

Price to Cash Flow

72

Interest Cover Ratio

29.0995

CFO/PAT (5 Yr. Avg.)

0.593588339181672

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 72.74 0.00
Dec 2024 72.74 0.00
Sep 2024 72.74 0.00
Jun 2024 72.74 0.00
Mar 2024 72.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 21.7110614150672% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 29.0995.
  • Company’s PEG ratio is 0.297195617004589.
  • The company has an efficient Cash Conversion Cycle of 38.0024 days.
  • Company has a healthy liquidity position with current ratio of 2.4145.
  • The company has a high promoter holding of 72.74%.

 Limitations

  • The company has shown a poor profit growth of -11.4459515308204% for the Past 3 years.
  • The company has shown a poor revenue growth of 8.41216758504155% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 84.81 95.61 88.03 91.41 86.83
Total Expenditure 73.86 83.01 81.72 80.79 83.28
Operating Profit 10.95 12.6 6.32 10.62 3.55
Other Income 4.19 4.16 6.27 5.43 0.15
Interest 0.28 0.46 0.44 0.32 0.6
Depreciation 2.07 2.06 2.14 2.3 2.3
Exceptional Items 0 0 0 0 0
Profit Before Tax 12.8 14.24 10 13.43 0.81
Tax 3.9 3.39 2.18 3.39 0.03
Profit After Tax 8.9 10.85 7.83 10.04 0.78
Adjusted EPS (Rs) 14.4 17.56 12.67 16.26 1.27

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 152.18 258.18 318.67 275.05 328.97
Total Expenditure 131.27 181.13 252.75 246.34 284.21
Operating Profit 20.91 77.05 65.92 28.71 44.76
Other Income 3.34 8.55 12.64 7.61 15.9
Interest 2.62 2.2 1.91 1.83 1.8
Depreciation 7.27 7.39 7.67 7.9 8.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.35 76 68.97 26.6 50.71
Tax 3.75 20.53 16.73 6.48 12.19
Net Profit 10.39 55.33 52.19 20.04 38.37
Adjusted EPS (Rs.) 17.16 89.79 84.57 32.57 62.35

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.09 3.09 3.09 3.09 3.09
Total Reserves 98.12 152.36 203.48 222.43 259.72
Borrowings 8.32 6.13 3.44 2.07 0.74
Other N/C liabilities 3.26 5 4.6 3.87 5.13
Current liabilities 42.79 39.21 63.12 56.65 84.36
Total Liabilities 155.58 205.8 277.72 288.11 353.05
Assets
Net Block 60.85 57.53 58.68 59.49 60.13
Capital WIP 0 0.91 6.31 26.31 45.52
Intangible WIP 0 0 0 0 0
Investments 3.73 3.73 3.73 3.73 3.73
Loans & Advances 8.35 20.17 36.4 35.01 35.36
Other N/C Assets 0.01 0 2.57 4.39 4.62
Current Assets 82.65 123.47 170.04 159.19 203.69
Total Assets 155.58 205.8 277.72 288.11 353.05
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 14.35 76 68.97 26.6 50.71
Adjustment 11 3.25 6.63 5.91 -1.12
Changes in Assets & Liabilities -1.98 -32.15 -43.06 5.86 -26.26
Tax Paid -3.75 -20.53 -16.73 -6.48 -12.19
Operating Cash Flow 19.62 26.57 15.82 31.89 11.14
Investing Cash Flow -18.78 -23.79 -16.13 -23.62 -17.49
Financing Cash Flow -1.3 -1.08 -1.08 -1.08 -1.08
Net Cash Flow -0.46 1.71 -1.4 7.19 -7.44

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 72.74 72.74 72.74 72.74 72.74
ajita nachane 11.55 11.55 11.55 11.55 11.55
pci ferrmone chemicals (i... - 8.38 - 8.38 8.38
rahul nachane 17.54 17.54 17.54 17.54 17.54
rajesh lawande 21.89 21.89 21.89 21.89 21.89
sunita potdar 13.38 13.38 13.38 13.38 13.38
pci ferrmone chemicals(in... - - 8.38 - -
pci ferrmone chemicals (i... 8.38 - - - -
pci ferrmone chemicals (i... 8.38 - - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 27.26 27.26 27.26 27.26 27.26
llp 0.03 0.04 0.04 0.04 0.04
yashkumar poonamchand gol... - - - - 1.05
debashish neogi - - 1.11 - -
debashish neogi 1.10 1.10 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

NGL Fine Chem informs about disclosure 19 Apr, 4:25 PM Ngl Fine-Chem informs about credit rating 6 Mar, 4:45 PM NGL Fine-Chem informs about outcome of board meeting 6 Mar, 12:37 PM NGL Fine-Chem informs about newspaper publication 10 Feb, 5:14 PM NGL Fine-Chem - Quaterly Results 7 Feb, 7:33 PM NGL Fine-Chem - Quaterly Results 7 Feb, 7:33 PM Ngl Fine-Chem informs about updates 6 Jan, 5:25 PM Ngl Fine-Chem informs about disclosure 23 Sep, 5:21 PM NGL Fine-Chem informs about disclosure 19 Aug, 12:59 PM NGL Fine-Chem informs about newspaper publication 16 Aug, 5:37 PM NGL Fine-Chem - Quaterly Results 12 Aug, 7:09 PM NGL Fine-Chem - Quaterly Results 12 Aug, 7:09 PM Ngl Fine-Chem informs about disclosure 18 Jun, 6:06 PM NGL Fine-Chem submits analyst meet outcome 1 Jun, 3:54 PM NGL Fine-Chem informs about revised investor presentation 28 May, 3:31 PM NGL Fine-Chem - Quaterly Results 21 May, 8:08 PM NGL Fine-Chem - Quaterly Results 21 May, 8:08 PM NGL Fine-Chem informs about issuance of letter of confirmation 2 May, 5:29 PM NGL Fine-Chem submits postal ballot notice 19 Mar, 11:08 AM NGL Fine-Chem informs about board meeting 11 Mar, 5:09 PM NGL Fine-Chem - Quaterly Results 12 Feb, 7:04 PM NGL Fine-Chem - Quaterly Results 12 Feb, 7:04 PM NGL Fine-Chem informs about board meeting 3 Feb, 11:54 AM Ngl Fine-Chem informs about loss of share certificate 16 Jan, 5:25 PM NGL Fine-Chem informs about issuance of letter of confirmation 1 Jan, 12:22 PM NGL Fine-Chem informs about investor presentation 17 Nov, 2:25 PM NGL Fine-Chem - Quaterly Results 10 Nov, 6:57 PM Ngl Fine-Chem informs about investor meet 8 Nov, 4:30 PM NGL Fine-Chem informs about closure of trading window 28 Sep, 2:35 PM NGL Fine-Chem informs about disclosure 18 Sep, 10:27 AM NGL Fine-Chem informs about disclosure 13 Sep, 2:02 PM NGL Fine-Chem informs about disclosure 11 Sep, 1:16 PM NGL Fine-Chem informs about disclosure 8 Sep, 5:20 PM NGL Fine-Chem - Quaterly Results 4 Aug, 7:17 PM NGL Fine-Chem - Quaterly Results 4 Aug, 7:17 PM NGL Fine-Chem informs about details of loss of certificate 28 Jul, 4:29 PM NGL Fine-Chem informs about credit rating 18 Jul, 2:19 PM NGL Fine-Chem informs about closure of trading window 28 Jun, 4:40 PM NGL Fine-Chem informs about details of loss of certificate 6 Jun, 12:31 PM NGL Fine-Chem - Quaterly Results 15 May, 6:24 PM NGL Fine-Chem - Quaterly Results 15 May, 6:24 PM NGL Fine-Chem informs about conference call 12 May, 3:31 PM NGL Fine-Chem informs about certificate 19 Apr, 4:23 PM NGL Fine-Chem informs about disclosure 22 Mar, 12:33 PM Ngl Fine-Chem informs about loss of share certificate 16 Mar, 4:57 PM Ngl Fine-Chem informs about disclosure 25 Feb, 3:41 PM NGL Fine-Chem informs about disclosure 25 Feb, 11:32 AM NGL Fine-Chem informs about disclosure 22 Feb, 12:16 PM NGL Fine-Chem - Quaterly Results 10 Feb, 6:14 PM NGL Fine-Chem - Quaterly Results 10 Feb, 6:14 PM

NGL Fine-Chem Stock Price Analysis and Quick Research Report. Is NGL Fine-Chem an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into NGL Fine-Chem and its performance over the period of time. NGL Fine-Chem stock price today is Rs 1285.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. NGL Fine-Chem cash from the operating activity was Rs 11.1377 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. NGL Fine-Chem has a Debt to Equity ratio of 0.1294 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In NGL Fine-Chem , the EPS growth was 91.4599 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, NGL Fine-Chem has OPM of 13.6058278338952 % which is a bad sign for profitability.
     
  • ROE: NGL Fine-Chem have a average ROE of 15.7761 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of NGL Fine-Chem is Rs 1285. One can use valuation calculators of ticker to know if NGL Fine-Chem share price is undervalued or overvalued.
Last Updated on:
Brief about NGL Fine-Chem

NGL Fine-Chem Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

NGL Fine-Chem Limited is a leading company in the chemical industry, specializing in the manufacturing and distribution of fine chemicals. With a strong presence in both domestic and international markets, NGL Fine-Chem Limited has established itself as a trusted name in the industry.

NGL Fine-Chem Limited - Share Price

Get real-time updates on NGL Fine-Chem Limited's share price, ensuring you stay informed and make well-informed investment decisions. Our pre-built screening tools allow you to easily track the performance of NGL Fine-Chem Limited's stock and analyze historical trends.

NGL Fine-Chem Limited - Balance Sheet

Analyze NGL Fine-Chem Limited's financial health through its balance sheet. Our premium features enable you to calculate the fair value of the company using various tools, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis. These tools provide valuable insights for long-term stock investors seeking in-depth stock analysis.

NGL Fine-Chem Limited - Annual Report

Access NGL Fine-Chem Limited's annual reports on our website. These comprehensive documents provide a detailed overview of the company's performance, strategy, and outlook. With downloadable annual reports, you can study NGL Fine-Chem Limited's financials at your convenience and make informed investment decisions.

NGL Fine-Chem Limited - Dividend

Stay up-to-date with NGL Fine-Chem Limited's dividend announcements. Our platform allows you to easily track dividend history and projections, helping you assess the company's dividend yield and potential returns. For long-term investors seeking stable income streams, NGL Fine-Chem Limited's dividend information is a valuable resource.

NGL Fine-Chem Limited - Quarterly Result

Monitor NGL Fine-Chem Limited's quarterly performance through our platform. Explore the company's financials and assess its growth trajectory. Our premium features enable you to evaluate the fair value of NGL Fine-Chem Limited's stock using a variety of analytical tools, providing a comprehensive analysis for long-term investors.

NGL Fine-Chem Limited - Stock Price

Stay updated with real-time stock prices of NGL Fine-Chem Limited. Through our platform, you can easily track the stock's performance and analyze historical price movements. Our pre-built screening tools allow you to identify trends and make informed investment decisions with ease.

NGL Fine-Chem Limited - Price Chart

Visualize NGL Fine-Chem Limited's stock performance with interactive price charts. Our platform provides comprehensive price charts that enable you to identify patterns, trends, and potential opportunities. Long-term investors can utilize these charts to make well-informed decisions based on historical trends and future projections.

NGL Fine-Chem Limited - News

Access the latest news and updates about NGL Fine-Chem Limited through our platform. Stay informed about important developments that may impact the company's stock performance. Our curated news section ensures you have access to relevant and timely information, empowering you to make informed investment decisions.

NGL Fine-Chem Limited - Concall Transcripts

Gain insights into NGL Fine-Chem Limited's conference call discussions with our downloadable concall transcripts. These transcripts provide a comprehensive record of management's remarks, investor questions, and key takeaways. Stay informed about the company's strategic initiatives, performance updates, and future plans through these valuable resources.

NGL Fine-Chem Limited - Investor Presentations

Access NGL Fine-Chem Limited's investor presentations on our website. These presentations provide a detailed overview of the company's operations, financials, and growth strategies. Stay updated on NGL Fine-Chem Limited's achievements, market positioning, and future prospects through these informative presentations.

NGL Fine-Chem Limited - Promoters

Understand the key individuals behind NGL Fine-Chem Limited's success. Our platform provides detailed information about NGL Fine-Chem Limited's promoters, allowing you to assess their experience, expertise, and influence on the company's performance. Gain insights into the leadership team that drives NGL Fine-Chem Limited's growth and success.

NGL Fine-Chem Limited - Shareholders

Explore NGL Fine-Chem Limited's shareholder information and ownership structure. Understand the major stakeholders and their influence on the company's decision-making processes. Our platform provides valuable insights into the distribution of ownership, enabling you to assess the stability and governance structure of NGL Fine-Chem Limited.

With a commitment to serving long-term stock investors, NGL Fine-Chem Limited offers a comprehensive stock analysis platform. Through our pre-built screening tools and premium features, you can analyze the company's performance, assess fair value using various tools, and access essential resources such as annual reports, concall transcripts, investor presentations, and credit ratings. Stay informed, make informed investment decisions, and maximize your returns with NGL Fine-Chem Limited's stock analysis platform. 

NGL Fine-Chem Balance Sheet Overview

Analyzing the NGL Fine-Chem Balance Sheet reveals a steady increase in total liabilities and assets over the period from March 2020 to March 2024. The data shows total liabilities grew from Rs. 155.58 Cr in March 2020 to Rs. 353.05 Cr by March 2024. Similarly, assets also paralleled this growth, maintaining balance as per the principles of accounting.

NGL Fine-Chem Increase in Reserves

There has been a significant boost in NGL Fine-Chem's total reserves, increasing from Rs. 98.12 Cr in March 2020 to Rs. 259.72 Cr by March 2024. This growth in reserves highlights the company's enhanced internal strength and financial stability over the years.

NGL Fine-Chem Debt Reduction

The company has demonstrated effective debt management with total borrowings decreasing dramatically from Rs. 8.32 Cr in March 2020 to just Rs. 0.74 Cr by March 2024. This reduction in debt underlines NGL Fine-Chem's commitment to maintaining a robust financial structure.

NGL Fine-Chem Asset Growth

The asset side of the balance sheet also saw a progressive increase, primarily in the current assets segment, which rose from Rs. 82.65 Cr in 2020 to Rs. 203.69 Cr by 2024. Significant growth in Capital WIP (Work In Progress) from nearly zero in 2020 to Rs. 45.52 Cr in 2024 suggests substantial ongoing project investments.

The above data is an analysis for the Standalone Balance Sheet of NGL Fine-Chem.

NGL Fine-Chem's financial trends are crucial for investors watching the pharmaceutical sector closely, especially considering market volatility and investment opportunities like IPOs and sectoral growth indices.

Read More
X